HOME >> BIOLOGY >> NEWS
Up to one-third of all cancer cases may be prevented by healthy diets and exercise, notes FANSA

CHICAGO -- Healthy diets and exercise may prevent as many cases of cancer in the United States as not smoking, according to a recent statement by the Food and Nutrition Science Alliance (FANSA). Cancer kills more than 500,000 Americans every year. In a review of cancer research, FANSA found overwhelmingly conclusive evidence that the risk of several types of cancer can be dramatically lowered through healthy dietary practices and exercise.

"In terms of cancer prevention, a healthy diet and exercise are as important as not smoking," says Dennis Savaiano, Ph.D., chair of FANSA and Professor of Foods and Nutrition at Purdue University. "Approximately one-third of cancer cases are attributed to smoking, one-third to poor diet and lack of exercise, and one-third to genetic or other factors. Most Americans are already aware of the detrimental effects of smoking, but poor diet is cause for alarm. We need to initiate changes in behavior now, in order to reduce the number of cancer-related deaths in the years to come."

The FANSA Statement, "Diet and Cancer Prevention in the United States," specifically urges Americans to take the following steps to reduce their cancer risk:

  • Eat plenty of fruits, vegetables, whole grains, and legumes in accordance with the USDA Food Guide Pyramid.
  • Avoid high calorie foods with little nutritional value.
  • Choose activities that involve moderate or vigorous exercise.
  • Limit or abstain from alcohol intake.

The FANSA statement, which can be viewed at www.faseb.org/ascn/fansa12-99.htm, is the first step in a nationwide call for action. In order to effect a change, all food, nutrition, fitness, health, and government organizations must strive to create consumer demand for a healthy lifestyle.


'"/>

Contact: Dennis Savaiano
savaiano@cfs.purdue.edu
765-494-8210
Institute of Food Technologists
23-Feb-2000


Page: 1

Related biology news :

1. Americans still consume one-third of calories from low-nutrient tip of the pyramid
2. Leader in cancer treatment and prevention research honored
3. International study findings link acne-like rash to effectiveness of new targeted cancer treatment
4. Chemical derived from vitamin-E shows early promise as cancer drug
5. New molecular link key to cellular proteins involved in cancer progression, other diseases
6. Phase II trials of second-generation antisense cancer drug planned following successful early study
7. Trial shows which brain cancer patients benefit from temozolomide
8. Genetic differences might help distinguish thyroid cancers
9. Evidence builds for potential new cancer drug target
10. New sequence involved in DNA replication timing may aid in cancer detection
11. Enzyme maintaining chromosome ends is linked to bone cancer recurrence, decreased survival

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/28/2016)... 28, 2016 First quarter 2016:   ... compared with the first quarter of 2015 The gross ... M (loss: 18.8) and the operating margin was 40% (-13) ... Cash flow from operations was SEK 249.9 M (21.2) , ... is unchanged, SEK 7,000-8,500 M. The operating margin for ...
(Date:4/15/2016)... -- Research and Markets has announced the ...  report to their offering.  ,      ... gait biometrics market is expected to grow at ... Gait analysis generates multiple variables such ... compute factors that are not or cannot be ...
(Date:3/29/2016)... BOCA RATON, Florida , March 29, 2016 /PRNewswire/ ... ("LegacyXChange" or the "Company") LegacyXChange "LEGX" and SelectaDNA/CSI Protect ... Synthetic DNA in ink used in a variety of ... preventing theft. Buyers of originally created collectibles from athletes ... authenticity through forensic analysis of the DNA. ...
Breaking Biology News(10 mins):
(Date:6/24/2016)... 24, 2016 Epic Sciences unveiled a ... susceptible to PARP inhibitors by targeting homologous recombination ... The new test has already been incorporated into ... cancer types. Over 230 clinical trials ... pathways, including PARP, ATM, ATR, DNA-PK and WEE-1. ...
(Date:6/23/2016)... , ... June 23, 2016 , ... ... release of its second eBook, “Clinical Trials Patient Recruitment and Retention Tips.” Partnering ... retention in this eBook by providing practical tips, tools, and strategies for clinical ...
(Date:6/23/2016)... , June 23, 2016 /PRNewswire/ - FACIT has ... Ontario biotechnology company, Propellon Therapeutics Inc. ... and commercialization of a portfolio of first-in-class WDR5 ... targets such as WDR5 represent an exciting class ... in precision medicine for cancer patients. Substantial advances ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... (Yeast and Mold) microbial test has received AOAC Research Institute approval 061601. , ... tests introduced last year,” stated Bob Salter, Vice President of Regulatory and Industrial ...
Breaking Biology Technology:
Cached News: